黑人肝硬化患者死亡率更高且移植率更低:一项大都市队列研究
该研究基于美国大都市区七个大型健康系统的电子健康记录数据,链接州死亡登记和国家移植数据库,纳入11277例肝硬化患者(黑人占22.2%),采用多变量竞争风险分析。结果显示黑人患者全因死亡率和非肝病相关死亡率最高,且被列入移植名单或接受移植的可能性更低(P<0.001);校正混杂因素后,黑人患者肝病相关死亡风险增加26%(subdistribution HR 1.26,95%CI 1.15-1.38,P<0.001)。
要点
- 黑人肝硬化患者全因死亡率和非肝病相关死亡率均高于白人患者。
- 黑人患者被列入移植名单或接受移植的比例显著低于白人患者(P<0.001)。
- 校正混杂因素后,黑人患者肝病相关死亡风险增加26%(subdistribution HR 1.26)。
核心结论
- 黑人肝硬化患者存在不一致的结局:死亡率更高且移植率更低。
研究设计与样本
- 研究分析了大都市人口学电子健康记录数据集,来自七个大型健康系统,并链接州死亡登记和国家移植数据库。
主要发现
- 研究期间共11277例患者符合纳入标准,其中2498例(22.2%)为黑人。
- 与白人患者相比,黑人患者年龄、性别、MELD-Na和酒精相关肝病比例相似,但合并症负担更高、私人保险比例更低、门脉高压并发症发生率更低。
- 黑人患者全因死亡率、非肝病相关死亡率最高,且被列入移植名单或接受移植的可能性更低(P<0.001)。
- 多变量竞争风险分析中,黑人患者肝病相关死亡的风险增加26%(subdistribution HR 1.26;95% CI 1.15-1.38;P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Estimates of racial disparity in cirrhosis have been limited by lack of large-scale, longitudinal data, which track patients from diagnosis to death and/or transplant. APPROACH AND RESULTS: We analyzed a large, metropolitan, population-based electronic health record data set from seven large health systems linked to the state death registry and the national transplant database. Multivariate competing risk analyses, adjusted for sex, age, insurance status, Elixhauser score, etiology of cirrhosis, HCC, portal hypertensive complication, and Model for End-Stage Liver Disease-Sodium (MELD-Na), examined the relationship between race, transplant, and cause of death as defined by blinded death certificate review. During the study period, 11,277 patients met inclusion criteria, of whom 2,498 (22.2%) identified as Black. Compared to White patients, Black patients had similar age, sex, MELD-Na, and proportion of alcohol-associated liver disease, but higher comorbidity burden, lower rates of private insurance, and lower rates of portal hypertensive complications. Compared to White patients, Black patients had the highest rate all-cause mortality and non-liver-related death and were less likely to be listed or transplanted (P < 0.001 for all). In multivariate competing risk analysis, Black patients had a 26% increased hazard of liver-related death (subdistribution HR, 1.26; 95% CI, [1.15-1.38]; P < 0.001). CONCLUSIONS: Black patients with cirrhosis have discordant outcomes. Further research is needed to determine how to address these real disparities in the field of hepatology.
引用
- Mazumder NR, Simpson D, Atiemo K, et al. Black Patients With Cirrhosis Have Higher Mortality and Lower Transplant Rates: Results From a Metropolitan Cohort Study. Hepatology. 2021. PMID: 34128254. doi:10.1002/hep.31742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。